Gold Standard Phantoms Limited is pleased to announce that it was successful in receiving funding of £100,000 from Innovate UK as part of the Precision Medicine competition for development of an automatic calibration software for standardisation of MR diffusion imaging, the most important quantitative imaging biomarker used for detection of early changes in prostate cancer.
